Prognostic value of lymphovascular space invasion determined with hematoxylin-eosin staining in early stage cervical carcinoma: results of a multivariate analysis

被引:66
作者
Morice, P
Piovesan, P
Rey, A
Atallah, D
Haie-Meder, C
Pautier, P
Sideris, L
Pomel, C
Duvillard, P
Castaigne, D
机构
[1] Inst Gustave Roussy, Dept Surg, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Dept Biostat, F-94805 Villejuif, France
[3] Inst Gustave Roussy, Dept Radiat Therapy, F-94805 Villejuif, France
[4] Inst Gustave Roussy, Dept Med Oncol, F-94805 Villejuif, France
[5] Inst Gustave Roussy, Dept Pathol, F-94805 Villejuif, France
关键词
cervical cancer; multivariate analysis; nodal involvement; vascular space invasion;
D O I
10.1093/annonc/mdg412
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Our aim was to study the prognostic value of the presence of lymphovascular space invasion (LVSI) in patients with stage IB and II cervical carcinoma treated by initial surgery. Patients and methods: A retrospective analysis was performed on 193 patients who underwent, between 1985 and 1998, an initial radical hysterectomy with pelvic (+/-para-aortic) lymphadenectomy using midline laparotomy for stage IB (180 patients) or II (13 patients) cervical carcinoma. Postoperative therapy was delivered according to prognostic factors. Results: The rate of LVSI correlated significantly with tumor stage, nodal status and the location of positive nodes. Using univariate analysis, tumor size (<4 or ≥4 cm), LVS status and nodal status were prognostic factors. At multivariate analysis, two prognostic factors were identified: LVS status and nodal status. In a subgroup of 89 patients with a small tumor (≤2 cm) and absence of nodal or isthmic involvement, the overall survival was significantly correlated with the presence of LVSI. Conclusions: LVSI is a frequent occurrence in patients with early stage cervical cancer. It represents an unfavorable prognostic factor in univariate and multivariate analyses. Such results suggest that improvement is needed in the treatment of patients with a small tumor and LVS invasion.
引用
收藏
页码:1511 / 1517
页数:7
相关论文
共 21 条
[1]  
[Anonymous], 1985, 38 ICRU
[2]   Operable stages IB and II cervical carcinomas: A retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy [J].
Atlan, D ;
Touboul, E ;
Deniaud-Alexandre, E ;
Lefranc, JP ;
Antoine, JM ;
Jannet, D ;
Lhuillier, P ;
Uzan, M ;
Huart, J ;
Genestie, C ;
Antoine, M ;
Jamali, M ;
Ganansia, V ;
Milliez, J ;
Uzan, S ;
Blondon, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (03) :780-793
[3]  
CREASMA IW, 2002, INT J GYNECOL CANCER, V12, P602
[4]   PROSPECTIVE SURGICAL PATHOLOGICAL-STUDY OF DISEASE-FREE INTERVAL IN PATIENTS WITH STAGE IB SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
DELGADO, G ;
BUNDY, B ;
ZAINO, R ;
SEVIN, BU ;
CREASMAN, WT ;
MAJOR, F .
GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :352-357
[5]  
GAUTHIER P, 1985, OBSTET GYNECOL, V66, P569
[6]   COMBINED RADIOTHERAPY AND SURGERY - LOCAL-CONTROL AND COMPLICATIONS IN EARLY CARCINOMA OF THE UTERINE CERVIX - THE VILLEJUIF EXPERIENCE, 1975-1984 [J].
GERBAULET, AL ;
KUNKLER, IH ;
KERR, GR ;
HAIE, C ;
MICHEL, G ;
PRADE, M ;
LHOMME, C ;
MASSELOT, M ;
ALBANO, M ;
DUTREIX, A ;
CHASSAGNE, D .
RADIOTHERAPY AND ONCOLOGY, 1992, 23 (02) :66-73
[7]  
GUILLERMIN P, 2002, 13 C SOC FRANC ONC G
[8]   LONG-TERM FOLLOW-UP OF STAGE-I CERVICAL ADENOCARCINOMA TREATED BY RADICAL SURGERY [J].
MCLELLAN, R ;
DILLON, MB ;
WOODRUFF, JD ;
HEATLEY, GJ ;
FIELDS, AL ;
ROSENSHEIN, NB .
GYNECOLOGIC ONCOLOGY, 1994, 52 (02) :253-259
[9]   Lymphatic spread in stage Ib and II cervical carcinoma: Anatomy and surgical implications [J].
Michel, G ;
Morice, P ;
Castaigne, D ;
Leblanc, M ;
Rey, A ;
Duvillard, P .
OBSTETRICS AND GYNECOLOGY, 1998, 91 (03) :360-363
[10]   Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination [J].
Morice, P ;
Juncker, L ;
Rey, A ;
El-Hassan, J ;
Haie-Meder, C ;
Castaigne, D .
FERTILITY AND STERILITY, 2000, 74 (04) :743-748